Historical award
We Pharma, Inc.
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (14 days old).
Fiscal year 2026: data through (14 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Potential award value
- $4,000,000.00
- Total obligated to date
- $99,919.36
Source date: Oct 14, 2026
Recorded work
IDIQ FOR PHARMACEUTICAL PRODUCTS FOR CDER RESEARCH STUDIES. INCLUDES BRAND NAME AND/OR GENERIC PHARMACEUTICALS TO INCLUDE SMALL MOLECULE AND PEPTIDE THERAPEUTICS, DRUG-DEVICE COMBINATION PRODUCTS, AND CONTRAST AGENTS. EO 14398
Award activity
- Obligations in covered fiscal years
- $99,919.36
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_IDV_75F40126D00023_7524